메뉴 건너뛰기




Volumn 5, Issue 1, 2014, Pages

Model-guided therapy for hepatocellular carcinoma: A role for information technology in predictive, preventive and personalized medicine

(16)  Berliner, Leonard a,b   Lemke, Heinz U c,d   vanSonnenberg, Eric e,f   Ashamalla, Hani a,b   Mattes, Malcolm D a   Dosik, David a,b   Hazin, Hesham a   Shah, Syed a,b   Mohanty, Smruti a,b   Verma, Sid a   Esposito, Giuseppe g   Bargellini, Irene h   Battaglia, Valentina h   Caramella, Davide h   Bartolozzi, Carlo h   Morrison, Paul i  


Author keywords

Bayesian network; Digital patient model; Hepatocellular carcinoma; Information technology; Model based medical evidence; Model guided therapy; Patient specific model; Personalized medicine; Therapy imaging and model management system; TIMMS

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOXETIC ACID;

EID: 84923228088     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1186/1878-5085-5-16     Document Type: Review
Times cited : (13)

References (61)
  • 1
    • 84870710995 scopus 로고    scopus 로고
    • General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine
    • 3485619, 23116135, EPMA
    • Golubnitschaja O, Costigliola V, . EPMA General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J 2012, 3:14. 10.1186/1878-5085-3-14, 3485619, 23116135, EPMA.
    • (2012) EPMA J , vol.3 , pp. 14
    • Golubnitschaja, O.1    Costigliola, V.2
  • 4
    • 78650445203 scopus 로고    scopus 로고
    • Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services, Accessed 7/27/2014
    • Armijo D, McDonnell C, Werner K. Electronic health record usability: evaluation and use case framework 2009, Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services, Accessed 7/27/2014. (http://www.himss.org/files/HIMSSorg/content/files/Code%20119%20-%20EHR%20Usability_Evaluation%20and%20Use%20Case%20Framework_AHRQ.pdf).
    • (2009) Electronic health record usability: evaluation and use case framework
    • Armijo, D.1    McDonnell, C.2    Werner, K.3
  • 5
    • 84927703420 scopus 로고    scopus 로고
    • Module 1. UML fundamentals
    • Berkley, CA: McGraw-Hill/Osborne
    • Roff JT. Module 1. UML fundamentals. UML: a Beginner's Guide 2003, Berkley, CA: McGraw-Hill/Osborne.
    • (2003) UML: a Beginner's Guide
    • Roff, J.T.1
  • 6
    • 84894277950 scopus 로고    scopus 로고
    • Personalised medicine and model-guided therapy
    • Dresden: Health Academy, Niederlag W, Lemke HU O, Rienhoff O
    • Lemke HU, Berliner L. Personalised medicine and model-guided therapy. Personalisierte Medizin und Informationstechnologie, 15 2010, 39-48. Dresden: Health Academy, Niederlag W, Lemke HU O, Rienhoff O.
    • (2010) Personalisierte Medizin und Informationstechnologie , vol.15 , pp. 39-48
    • Lemke, H.U.1    Berliner, L.2
  • 7
    • 84878383914 scopus 로고    scopus 로고
    • Personalised medicine and patient-specific modelling
    • Dresden: Health Academy, Niederlag W, Lemke HU, Golubnitschaja O, Rienhoff O
    • Lemke HU, Berliner L. Personalised medicine and patient-specific modelling. Personalisierte Medizin, 14 2010, 155-164. Dresden: Health Academy, Niederlag W, Lemke HU, Golubnitschaja O, Rienhoff O.
    • (2010) Personalisierte Medizin , vol.14 , pp. 155-164
    • Lemke, H.U.1    Berliner, L.2
  • 8
    • 37249020564 scopus 로고    scopus 로고
    • MEBN: a language for first-order Bayesian knowledge bases
    • Laskey KB. MEBN: a language for first-order Bayesian knowledge bases. Artif Intell 2008, 172:140-178.
    • (2008) Artif Intell , vol.172 , pp. 140-178
    • Laskey, K.B.1
  • 12
    • 79959294956 scopus 로고    scopus 로고
    • Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy
    • 21689611
    • Roskams T. Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy. Clin Liver Dis 2011, 15:245-259. 10.1016/j.cld.2011.03.004, 21689611.
    • (2011) Clin Liver Dis , vol.15 , pp. 245-259
    • Roskams, T.1
  • 13
    • 77951622187 scopus 로고    scopus 로고
    • Viral hepatocarcinogenesis
    • 3148694, 20228847
    • Tsai W-L, Chung RT. Viral hepatocarcinogenesis. Oncogene 2010, 29:2309-2324. 10.1038/onc.2010.36, 3148694, 20228847.
    • (2010) Oncogene , vol.29 , pp. 2309-2324
    • Tsai, W.-L.1    Chung, R.T.2
  • 14
    • 33748114343 scopus 로고    scopus 로고
    • The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
    • 16879891
    • Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45:529-538. 10.1016/j.jhep.2006.05.013, 16879891.
    • (2006) J Hepatol , vol.45 , pp. 529-538
    • Perz, J.F.1    Armstrong, G.L.2    Farrington, L.A.3    Hutin, Y.J.4    Bell, B.P.5
  • 15
    • 34250020201 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
    • 17570226
    • El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576. 10.1053/j.gastro.2007.04.061, 17570226.
    • (2007) Gastroenterology , vol.132 , pp. 2557-2576
    • El-Serag, H.B.1    Rudolph, K.L.2
  • 16
    • 0032579547 scopus 로고    scopus 로고
    • A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
    • 9455792
    • Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998, 75:347-354. 10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2, 9455792.
    • (1998) Int J Cancer , vol.75 , pp. 347-354
    • Donato, F.1    Boffetta, P.2    Puoti, M.3
  • 19
    • 58149460674 scopus 로고    scopus 로고
    • Treatment failure in hepatitis C: mechanisms of non-response
    • 2743341, 19070928
    • Tai AW, Chung RT. Treatment failure in hepatitis C: mechanisms of non-response. J Hepatol 2009, 50:412-420. 10.1016/j.jhep.2008.11.010, 2743341, 19070928.
    • (2009) J Hepatol , vol.50 , pp. 412-420
    • Tai, A.W.1    Chung, R.T.2
  • 20
    • 58849143425 scopus 로고    scopus 로고
    • The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology
    • Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 2009, 44(Suppl XIX):96-101.
    • (2009) J Gastroenterol , vol.44 , pp. 96-101
    • Caldwell, S.1    Park, S.H.2
  • 21
    • 0037325438 scopus 로고    scopus 로고
    • Natural history and prognosis of hepatitis B
    • Fattovich G. Natural history and prognosis of hepatitis B. Sem Liver Diseas 2003, 23:47-58.
    • (2003) Sem Liver Diseas , vol.23 , pp. 47-58
    • Fattovich, G.1
  • 22
    • 0034027972 scopus 로고    scopus 로고
    • Improved survival with screening for hepatocellular carcinoma
    • 10827233
    • Wong LL, Limm WM, Severino R, Wong LM. Improved survival with screening for hepatocellular carcinoma. Liver Transpl 2000, 6:320-325. 10.1053/lv.2000.4875, 10827233.
    • (2000) Liver Transpl , vol.6 , pp. 320-325
    • Wong, L.L.1    Limm, W.M.2    Severino, R.3    Wong, L.M.4
  • 23
    • 3843125293 scopus 로고    scopus 로고
    • Randomized controlled trial of screening for hepatocellular carcinoma
    • Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130:417-422.
    • (2004) J Cancer Res Clin Oncol , vol.130 , pp. 417-422
    • Zhang, B.H.1    Yang, B.H.2    Tang, Z.Y.3
  • 24
    • 77958070977 scopus 로고    scopus 로고
    • Current treatment strategies for hepatocellular carcinoma
    • Aronsohn A, Mohanty SR. Current treatment strategies for hepatocellular carcinoma. Curr Cancer Ther Rev 2010, 6:199-206.
    • (2010) Curr Cancer Ther Rev , vol.6 , pp. 199-206
    • Aronsohn, A.1    Mohanty, S.R.2
  • 25
    • 0035128185 scopus 로고    scopus 로고
    • Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
    • 1728189, 11156649
    • Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001, 48:251-259. 10.1136/gut.48.2.251, 1728189, 11156649.
    • (2001) Gut , vol.48 , pp. 251-259
    • Bolondi, L.1    Sofia, S.2    Siringo, S.3    Gaiani, S.4    Casali, A.5    Zironi, G.6    Piscaglia, F.7    Gramantieri, L.8    Zanetti, M.9    Sherman, M.10
  • 26
    • 0025248538 scopus 로고
    • Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review
    • Wu JT. Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review. Ann Clin Lab Sci 1990, 20:98-105.
    • (1990) Ann Clin Lab Sci , vol.20 , pp. 98-105
    • Wu, J.T.1
  • 27
    • 0035059885 scopus 로고    scopus 로고
    • Alphafetoprotein: an obituary
    • 11394662
    • Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001, 34:603-605. 10.1016/S0168-8278(01)00025-3, 11394662.
    • (2001) J Hepatol , vol.34 , pp. 603-605
    • Sherman, M.1
  • 28
    • 0032879468 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: the BCLC staging classification
    • 10518312
    • Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999, 19:329-338. 10.1055/s-2007-1007122, 10518312.
    • (1999) Semin Liver Dis , vol.19 , pp. 329-338
    • Llovet, J.M.1    Bru, C.2    Bruix, J.3
  • 29
    • 84858658381 scopus 로고    scopus 로고
    • European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
    • European Association for the Study of the Liver
    • European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012, 56:908-943. European Association for the Study of the Liver.
    • (2012) J Hepatol , vol.56 , pp. 908-943
  • 30
    • 79952231921 scopus 로고    scopus 로고
    • AASLD PRACTICE GUIDELINE. Management of hepatocellular carcinoma: an update
    • 3084991, 21374666
    • Sherman M, Bruix J. AASLD PRACTICE GUIDELINE. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022. 10.1002/hep.24199, 3084991, 21374666.
    • (2011) Hepatology , vol.53 , pp. 1020-1022
    • Sherman, M.1    Bruix, J.2
  • 31
    • 79951791027 scopus 로고    scopus 로고
    • AASLD Practice Guideline. Management of hepatocellular carcinoma
    • Accessed 20 November 2011
    • Bruix J, Sherman M. AASLD Practice Guideline. Management of hepatocellular carcinoma. Hepatology 2010, http://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/HCCUpdate2010.pdf. Accessed 20 November 2011.
    • (2010) Hepatology
    • Bruix, J.1    Sherman, M.2
  • 32
    • 42949174616 scopus 로고    scopus 로고
    • Diagnosis and treatment of hepatocellular carcinoma
    • 18471552
    • El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008, 134:1752-1763. 10.1053/j.gastro.2008.02.090, 18471552.
    • (2008) Gastroenterology , vol.134 , pp. 1752-1763
    • El-Serag, H.B.1    Marrero, J.A.2    Rudolph, L.3    Reddy, K.R.4
  • 34
    • 0035986529 scopus 로고    scopus 로고
    • Dysplastic nodules and hepatocarcinogenesis
    • 12122867
    • Theise ND, Park YN, Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002, 6:497-512. 10.1016/S1089-3261(02)00006-5, 12122867.
    • (2002) Clin Liver Dis , vol.6 , pp. 497-512
    • Theise, N.D.1    Park, Y.N.2    Kojiro, M.3
  • 35
    • 61949171989 scopus 로고    scopus 로고
    • Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia
    • International Consensus Group for Hepatocellular Neoplasia
    • International Consensus Group for Hepatocellular Neoplasia Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 2009, 49:658-664. International Consensus Group for Hepatocellular Neoplasia.
    • (2009) Hepatology , vol.49 , pp. 658-664
  • 36
    • 84879502464 scopus 로고    scopus 로고
    • Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers
    • 23053453
    • Bartolozzi C, Battaglia V, Bargellini I, Bozzi E, Campani D, Pollina LE, Filipponi F. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. Abdom Imaging 2013, 38:290-296. 10.1007/s00261-012-9952-9, 23053453.
    • (2013) Abdom Imaging , vol.38 , pp. 290-296
    • Bartolozzi, C.1    Battaglia, V.2    Bargellini, I.3    Bozzi, E.4    Campani, D.5    Pollina, L.E.6    Filipponi, F.7
  • 39
    • 21344450714 scopus 로고    scopus 로고
    • Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma
    • Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005, 42:27-34.
    • (2005) Hepatology , vol.42 , pp. 27-34
    • Bolondi, L.1    Gaiani, S.2    Celli, N.3    Golfieri, R.4    Grigioni, W.F.5    Leoni, S.6    Venturi, A.M.7    Piscaglia, F.8
  • 41
    • 84876698401 scopus 로고    scopus 로고
    • Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (≤2.0 cm) in patients with hepatitis-induced liver cirrhosis
    • 23148300
    • Park MJ, Kim YK, Lee MH, Lee JH. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (≤2.0 cm) in patients with hepatitis-induced liver cirrhosis. Acta Radiol 2013, 54:127-136. 10.1258/ar.2012.120262, 23148300.
    • (2013) Acta Radiol , vol.54 , pp. 127-136
    • Park, M.J.1    Kim, Y.K.2    Lee, M.H.3    Lee, J.H.4
  • 42
    • 84866606349 scopus 로고    scopus 로고
    • Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC
    • 22891358
    • Kim YK, Lee WJ, Park MJ, Kim SH, Rhim H, Choi D. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Radiology 2012, 265:104-114. 10.1148/radiol.12112649, 22891358.
    • (2012) Radiology , vol.265 , pp. 104-114
    • Kim, Y.K.1    Lee, W.J.2    Park, M.J.3    Kim, S.H.4    Rhim, H.5    Choi, D.6
  • 43
    • 84865423409 scopus 로고    scopus 로고
    • Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns
    • 22843769
    • Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology 2012, 264:761-770. 10.1148/radiol.12112517, 22843769.
    • (2012) Radiology , vol.264 , pp. 761-770
    • Park, M.J.1    Kim, Y.K.2    Lee, M.W.3    Lee, W.J.4    Kim, Y.S.5    Kim, S.H.6    Choi, D.7    Rhim, H.8
  • 44
    • 0034541463 scopus 로고    scopus 로고
    • Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging
    • 11012437
    • Ichikawa T, Cederle MP, Grazioli L, Marsh W. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging. Radiology 2000, 217:145-151. 10.1148/radiology.217.1.r00se46145, 11012437.
    • (2000) Radiology , vol.217 , pp. 145-151
    • Ichikawa, T.1    Cederle, M.P.2    Grazioli, L.3    Marsh, W.4
  • 45
    • 39149092066 scopus 로고    scopus 로고
    • Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions
    • 17994317
    • Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008, 18:486-492. 10.1007/s00330-007-0798-4, 17994317.
    • (2008) Eur Radiol , vol.18 , pp. 486-492
    • Gourtsoyianni, S.1    Papanikolaou, N.2    Yarmenitis, S.3    Maris, T.4    Karantanas, A.5    Gourtsoyiannis, N.6
  • 47
    • 77956112733 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging-correlation with molecular transporters and histopathologic features
    • 20663969
    • Kitao A, Zen Y, Matsui O, Gabata T, Kobayashi S, Koda W, Kozaka K, Yoneda N, Yamashita T, Kaneko S, Nakanuma Y. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging-correlation with molecular transporters and histopathologic features. Radiology 2010, 256:817-826. 10.1148/radiol.10092214, 20663969.
    • (2010) Radiology , vol.256 , pp. 817-826
    • Kitao, A.1    Zen, Y.2    Matsui, O.3    Gabata, T.4    Kobayashi, S.5    Koda, W.6    Kozaka, K.7    Yoneda, N.8    Yamashita, T.9    Kaneko, S.10    Nakanuma, Y.11
  • 48
    • 67049172143 scopus 로고    scopus 로고
    • Gadoxetic-acid enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma
    • 19457834
    • Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK. Gadoxetic-acid enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009, 192:1675-1681. 10.2214/AJR.08.1262, 19457834.
    • (2009) AJR Am J Roentgenol , vol.192 , pp. 1675-1681
    • Kim, S.H.1    Kim, S.H.2    Lee, J.3    Kim, M.J.4    Jeon, Y.H.5    Park, Y.6    Choi, D.7    Lee, W.J.8    Lim, H.K.9
  • 49
    • 33846212284 scopus 로고    scopus 로고
    • Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
    • 17178882
    • Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 2006, 66:11851-11858. 10.1158/0008-5472.CAN-06-1377, 17178882.
    • (2006) Cancer Res , vol.66 , pp. 11851-11858
    • Liu, L.1    Cao, Y.2    Chen, C.3    Zhang, X.4    McNabola, A.5    Wilkie, D.6    Wilhelm, S.7    Lynch, M.8    Carter, C.9
  • 50
    • 84866606067 scopus 로고    scopus 로고
    • Complications of microwave ablation for liver tumors: results of a multicenter study
    • 21833809, for the Collaborative Italian Group using AMICA system
    • Livraghi T, Meloni F, Solbiati L, Zanus G, . for the Collaborative Italian Group using AMICA system Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol 2012, 35:868-874. 10.1007/s00270-011-0241-8, 21833809, for the Collaborative Italian Group using AMICA system.
    • (2012) Cardiovasc Intervent Radiol , vol.35 , pp. 868-874
    • Livraghi, T.1    Meloni, F.2    Solbiati, L.3    Zanus, G.4
  • 53
    • 84874771937 scopus 로고    scopus 로고
    • Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial
    • 23269991
    • Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013, 31:426-432. 10.1200/JCO.2012.42.9936, 23269991.
    • (2013) J Clin Oncol , vol.31 , pp. 426-432
    • Peng, Z.W.1    Zhang, Y.J.2    Chen, M.S.3    Xu, L.4    Liang, H.H.5    Lin, X.J.6    Guo, R.P.7    Zhang, Y.Q.8    Lau, W.Y.9
  • 54
    • 84897067851 scopus 로고    scopus 로고
    • Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology
    • [Epub ahead of print 2013 May 30], 23719667
    • Bargellini I, Florio F, Golfieri R, Grosso M, Lauretti DL, Cioni R. Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology. Cardiovasc Intervent Radiol 2014, 37:438-444. [Epub ahead of print 2013 May 30], 10.1007/s00270-013-0656-5, 23719667.
    • (2014) Cardiovasc Intervent Radiol , vol.37 , pp. 438-444
    • Bargellini, I.1    Florio, F.2    Golfieri, R.3    Grosso, M.4    Lauretti, D.L.5    Cioni, R.6
  • 55
    • 84864052036 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy
    • 22142656
    • Lencioni R. Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy. Crit Rev Oncol Hematol 2012, 83:216-224. 10.1016/j.critrevonc.2011.10.008, 22142656.
    • (2012) Crit Rev Oncol Hematol , vol.83 , pp. 216-224
    • Lencioni, R.1
  • 56
    • 84860261590 scopus 로고    scopus 로고
    • Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): phase II, randomized, double-blind SPACE trial. [abstract LBA154]
    • Lencioni R, Llovet JM, Han G, Tak W-Y, Yang J, Leberre M-A, Niu W, Nicholson K, Meinhardt G, Bruix J. Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): phase II, randomized, double-blind SPACE trial. [abstract LBA154]. J Clin Oncol 2012, 30(Suppl 4):40.
    • (2012) J Clin Oncol , vol.30 , pp. 40
    • Lencioni, R.1    Llovet, J.M.2    Han, G.3    Tak, W.-Y.4    Yang, J.5    Leberre, M.-A.6    Niu, W.7    Nicholson, K.8    Meinhardt, G.9    Bruix, J.10
  • 59
    • 34247095550 scopus 로고    scopus 로고
    • Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium
    • 17448867
    • Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007, 68:13-23. 10.1016/j.ijrobp.2006.11.060, 17448867.
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , pp. 13-23
    • Kennedy, A.1    Nag, S.2    Salem, R.3    Murthy, R.4    McEwan, A.J.5    Nutting, C.6    Benson, A.7    Espat, J.8    Bilbao, J.I.9    Sharma, R.A.10    Thomas, J.P.11    Coldwell, D.12
  • 61
    • 84927703419 scopus 로고    scopus 로고
    • Accessed November 17, 2013, Bayesian networks
    • Bayesian networks http://www.pr-owl.org/basics/bn.php#pearl1988 Accessed November 17, 2013, Bayesian networks.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.